Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity

Journal: Nature Communications

Published: 2020-09-15

DOI: 10.1038/s41467-020-18388-7

Affiliations: 7

Authors: 18

Go to article
Institutions Share
University Children's Hospital of Zurich, Switzerland 0.53
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands 0.14
NIH NCI Center for Cancer Research (CCR), United States of America (USA) 0.11
University Hospital Zurich (UHZ), Switzerland 0.06
Cancer, Heterogeneity, Instability and Plasticity (CHIP), France 0.06
Ligue Contre Le Cancer, France 0.06
Tata Memorial Hospital (TMH), TMC, India 0.06

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER